**Personal Doctors Key to Early Detection of Hepatitis B and C, Minister Says**
In a recent educational seminar titled “Hepatitis: From Diagnosis to Treatment,” Health Minister Neophytos Charalambides emphasized the vital role personal doctors play in the early detection of hepatitis B and C. The seminar, held on Saturday, was organized collaboratively by the health ministry’s medical and public health services, the Cyprus Medical Association, the Cyprus Society of Gastroenterology, the Cyprus Society of General Medicine, and the Cyprus Society of Personal and Family Doctors.
Charalambides highlighted the significant advancements in medical science that have improved the diagnosis and management of hepatitis B and C. He pointed out that while there are effective vaccines and treatments available, the challenge remains in ensuring that these medical advancements reach patients in a timely manner.
“Today, we have at our disposal a safe and effective vaccine for the prevention of hepatitis B, as well as treatments that can control chronic disease and reduce the risk of serious complications,” Charalambides stated. He further noted that modern antiviral treatments for hepatitis C boast a cure rate exceeding 95 percent.
Despite these advancements, the minister cautioned that chronic infections with hepatitis B and C can often be asymptomatic for extended periods. This lack of obvious symptoms can result in individuals remaining undiagnosed, missing out on critical monitoring and treatment opportunities. Personal doctors, who maintain regular contact with patients and are familiar with their medical histories, are in a unique position to identify potential signs that warrant further investigation.
“The proper assessment of risk factors and laboratory findings, as well as timely referral, can have a decisive impact on the progression of a case,” Charalambides explained. He underscored the necessity of continuous training for primary healthcare doctors to enhance the effective management of viral hepatitis.
Additionally, the minister stressed the importance of having a comprehensive understanding of the epidemiological landscape of hepatitis in Cyprus. “Completeness and accuracy in the notification of cases allow us to assess the real needs, identify gaps, and better plan public health interventions,” he remarked. In line with this goal, the health ministry has re-established the national committee dedicated to tackling viral hepatitis, expanding its focus to encompass all forms of the virus.
Charalambides also addressed the social stigma associated with viral hepatitis, noting that misconceptions about its transmission can lead to fear and discrimination. Such stigma may discourage individuals from seeking testing or medical assistance. “Scientifically sound information protects both public health and the dignity of patients,” he stated.
Concluding his address, Charalambides set an ambitious target for the future: the elimination of viral hepatitis as a public health threat by 2030. He acknowledged that achieving this goal would necessitate coordinated efforts from the state, healthcare professionals, scientific bodies, and patient organizations.
The seminar served as a platform for healthcare professionals to discuss the latest developments in hepatitis diagnosis and treatment, aiming to enhance awareness and improve health outcomes for individuals at risk. The collaboration among various medical societies underscores a unified approach to addressing the challenges posed by viral hepatitis in Cyprus.
As the health ministry continues to advocate for early detection and treatment, the role of personal doctors will be crucial in bridging the gap between patients and the healthcare system, ensuring that those at risk receive the necessary care and support.